CMHC will speak to sociodemographic inequities in cardiometabolic care
Converging via virtual format, the Cardiometabolic Health Congress will bring together cardiologists, endocrinologists and primary care physicians to view perspective on research and discuss inequalities in cardiometabolic care.
In its 15th year, the Cardiometabolic Health Congress (CMHC) will take place as a virtual experience from Oct. 21 to 24 and highlight the crossroads of cardiometabolic care and social determinants of health.
“This year, CMHC is more than timely,” Cardiology Today Editorial Board Member Keith C. Ferdinand, MD, FACC, FAHA, FASPC, Gerald S. Berenson Chair in Preventive Cardiology and professor of medicine at Tulane University School of Medicine, told Healio. “It addresses issues that have dominated not only the medical, but the lay public’s consciousness related to disparities in health and how we as a country can do better to remove inequities.
“There will be specific data presented that outline in detail these unacceptable persistent disparities in cardiometabolic health, and more importantly, leading experts in the field of cardiovascular medicine, endocrinology, primary care and other aspects of cardiometabolic health will present new and evolving data and concepts that will define best practices going forward,” Ferdinand said in an interview.
The first day of the virtual CMHC will include a preconference session, titled “Impact of Ethnicity and Race in Cardiometabolic Health.” Participants in this session will discuss inequities faced by patients living in food deserts, how providers can help to navigate health care costs, culturally informed treatment strategies and more.
Eugene Braunwald, MD, Distinguished Hersey Professor of Medicine at Harvard Medical School, founding chair of the TIMI Study Group at the Brigham and Women’s Hospital and Cardiology Today Editorial Board Member, will deliver a keynote address on day 2 of the meeting, titled “Evolving Paradigms in Cardiovascular Research and Care: Reflections and Perspectives.”
The remainder of the meeting will cover research topics and guidance in dyslipidemia, atherosclerosis, thrombosis, diabetes, obesity and lifestyle management.
“Cardiometabolic health, especially new and novel antihyperglycemic agents, is a field of medicine that involves a wide range of specialists, including cardiologists, internists, endocrinologists, nephrologists, pharmacists, advanced practice nurses and others,” Ferdinand told Healio. “Attendees to the CMHC can trust that they will hear new and emerging data and receive expert opinions that will help define best practices for 2020 and beyond.”
Stay tuned to Healio.com/Cardiology for news and updates from CMHC.
Collapse
Healio Coverage
Read more about